MAOA and depressive symptom measurement: Synthetic, irreversible MAO-A inhibitors (clorgyline) showed critical side effects, and reversible MAO-A inhibitors (moclobemide, brofaromine, toloxatone) are clinically applied for the treatment of anxiety and depression.